Inside a Campaign to Get Medicare Coverage for a New Alzheimer’s Drug
The Alzheimer’s Association has pushed relentlessly to get broad access [...]
The Alzheimer’s Association has pushed relentlessly to get broad access [...]
The agency’s accelerated approval program for certain drugs has come [...]
The narrow 50-46 decision underscored the divisions on both sides [...]
Medicare officials are trying to determine whether to cover Aduhelm, [...]
A higher Medicare premium in 2022 is just part of [...]
A group of Alzheimer’s experts and health advocates called on [...]
The drug, Aduhelm, has been mired in controversy since it [...]
The drug, Aduhelm, brought in $300,000 in revenue in its [...]
The agency approved Biogen’s Aduhelm “despite concerns raised by experts,” [...]
For an increasingly important set of drugs, Medicare has been [...]